2-{[1-(cyclohexylmethyl)-1H-indazol-3-yl]formamido}-3-methylbutanedioic acid
Structure Info
- Chemspace ID
- CSSB00159249847 (In-Stock Building Blocks)
- IUPAC Name
- 2-{[1-(cyclohexylmethyl)-1H-indazol-3-yl]formamido}-3-methylbutanedioic acid
- Mol formula
- C20H25N3O5
- Mol weight
- 387 Da
- Catalog Number(s)
- A106025, AA01EP6W, AG01EP9O, AX65348, CSC159249847, P991813, ST01EQQG, TX01EQFC
- Copy structure to query editor
- SMILES
- INCHI
- INCHI key
- MOL
Properties
- LogP
- 2.94
- Heavy atoms count
- 28
- Rotatable bond count
- 7
- Number of rings
- 3
- Carbon bond saturation, Fsp3
- 0.5
- Polar surface area (Å)
- 122
- Hydrogen bond acceptors count
- 6
- Hydrogen bond donors count
- 3
![Chemical structure of 2-{[1-(cyclohexylmethyl)-1H-indazol-3-yl]formamido}-3-methylbutanedioic acid (C20H25N3O5) - CSSB00159249847](/st/structure/200/a1113be4ecbc45ddbf95e11398cacbce/CC%2528C%2528NC%2528%253DO%2529C1%253DNN%2528CC2CCCCC2%2529C2%253DCC%253DCC%253DC12%2529C%2528O%2529%253DO%2529C%2528O%2529%253DO.png "C20H25N3O5")
- Zoom the structure
- CSSB00159249847
Items Overall 5 items from 5 suppliers
| Supplier | Lead time | Ships from | Purity | Pack | Price, $ | Qty |
|---|---|---|---|---|---|---|
| 1st Scientific LLC | 3 days | United States To: | 95 | 1 mg | 259.60 | |
Description: AB-CHMINACA metabolite M7; CAS: 2748157-34-6 | ||||||
| Angene US | 10 days | United States To: | 95 | 1 mg | 315.00 | |
Description: AB-CHMINACA metabolite M7; CAS: 2748157-34-6 | ||||||
| A2B Chem | 12 days | United States To: | 90 | 1 mg | 281.75 | |
Description: AB-CHMINACA metabolite M7; CAS: 2748157-34-6 | ||||||
| AA BLOCKS | 12 days | United States To: | 95 | 1 mg | 300.30 | |
Description: AB-CHMINACA metabolite M7; CAS: 2748157-34-6 | ||||||
| 10X CHEM | TBD | United States To: | 95 | 1 mg | 217.80 | |
Description: AB-CHMINACA metabolite M7; CAS: 2748157-34-6 | ||||||
For a custom pack size or bulk
please drop us a line:Enquire
please drop us a line:Enquire
Similarity Analogs
![Chemical structure of 3-carbamoyl-3-{[1-(cyclohexylmethyl)-1H-indazol-3-yl]formamido}-2-methylpropanoic acid - CSSB00159239438](/st/structure/200/deb07801773bc576f9c2e0c5767c2d31/CC%2528C%2528NC%2528%253DO%2529C1%253DNN%2528CC2CCCCC2%2529C2%253DCC%253DCC%253DC12%2529C%2528N%2529%253DO%2529C%2528O%2529%253DO.png)
![Chemical structure of (2S)-2-{[1-(cyclohexylmethyl)-1H-indazol-3-yl]formamido}-3,3-dimethylbutanoic acid - CSSB00102520504](/st/structure/200/7b6eda5fc575eea27a2cea4acd0300a9/CC%2528C%2529%2528C%2529%255BC%2540H%255D%2528NC%2528%253DO%2529C1%253DNN%2528CC2CCCCC2%2529C2%253DCC%253DCC%253DC12%2529C%2528O%2529%253DO.png)
![Chemical structure of (2S)-2-({1-[(4-hydroxycyclohexyl)methyl]-1H-indazol-3-yl}formamido)-3-methylbutanoic acid - CSSB00159239437](/st/structure/200/79cfabff748ca681fdcfb7ee6966dd38/CC%2528C%2529%255BC%2540H%255D%2528NC%2528%253DO%2529C1%253DNN%2528CC2CCC%2528O%2529CC2%2529C2%253DCC%253DCC%253DC12%2529C%2528O%2529%253DO.png)
![Chemical structure of (2S)-2-({1-[(4-hydroxycyclohexyl)methyl]-1H-indazol-3-yl}formamido)-3,3-dimethylbutanoic acid - CSSB00159259797](/st/structure/200/a9796fb501863ee7bd6c99fd55c84209/CC%2528C%2529%2528C%2529%255BC%2540H%255D%2528NC%2528%253DO%2529C1%253DNN%2528CC2CCC%2528O%2529CC2%2529C2%253DCC%253DCC%253DC12%2529C%2528O%2529%253DO.png)
![Chemical structure of methyl (2S)-2-{[1-(cyclohexylmethyl)-1H-indazol-3-yl]formamido}-3-methylbutanoate - CSSB00159239436](/st/structure/200/ae0e9b5b209467ff1a378d29d90b8466/COC%2528%253DO%2529%255BC%2540%2540H%255D%2528NC%2528%253DO%2529C1%253DNN%2528CC2CCCCC2%2529C2%253DCC%253DCC%253DC12%2529C%2528C%2529C.png)
![Chemical structure of (2S)-2-{[1-(5-fluoropentyl)-1H-indazol-3-yl]formamido}-3-methylbutanoic acid - CSSB06657276470](/st/structure/200/b1e8e2f6d039736fa6c769726bc10653/CC%2528C%2529%255BC%2540H%255D%2528NC%2528%253DO%2529c1nn%2528CCCCCF%2529c2ccccc12%2529C%2528O%2529%253DO.png)
![Chemical structure of (2S)-3-methyl-2-[(1-pentyl-1H-indazol-3-yl)formamido]butanoic acid - CSSB06256079160](/st/structure/200/e01def1bedfa0604effde1e267d88be5/CCCCCn1nc%2528C%2528%253DO%2529N%255BC%2540%2540H%255D%2528C%2528C%2529C%2529C%2528O%2529%253DO%2529c2ccccc12.png)
